Incentives and accessibility: a pilot study to promote adherence to TB prophylaxis in a high-risk community

J Urban Health. 1999 Dec;76(4):461-7. doi: 10.1007/BF02351503.

Abstract

Setting: A community-based directly observed preventive therapy (DOPT) program for treatment of latent tuberculosis infection among injection drug users (IDUs) in an inner-city neighborhood.

Objective: To test adherence to a 6-month course of DOPT using cash incentives and an easily accessible neighborhood location.

Design: Street-recruited IDUs (N = 205) were screened for Mycobacterium tuberculosis (TB) infection using the Mantoux test and two controls. Subjects who had a purified protein derivative (PPD) reaction of > or =5 mm, were anergic, or had a history of a positive PPD received clinical evaluation at a community field site, provided in collaboration with the San Francisco Department of Public Health Tuberculosis Clinic. Twenty-eight subjects were considered appropriate candidates for prophylaxis with isoniazid, and 27 enrolled in the pilot study. Participants received twice-weekly DOPT at a community satellite office, with a $10 cash incentive at each visit.

Results: The 6-month (26-week) regimen was completed by 24/27 (89%) participants. The median time to treatment completion was 27 weeks (range 26 to 34 weeks). The median proportion of dosing days attended in 6 months was 96%.

Conclusion: Community-based DOPT using cash incentives resulted in high levels of adherence and treatment completion among drug users.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Antitubercular Agents / administration & dosage*
  • Community Health Services*
  • Drug Administration Schedule
  • Female
  • Health Services Accessibility*
  • Humans
  • Isoniazid / administration & dosage
  • Male
  • Mass Screening
  • Patient Compliance*
  • Pilot Projects
  • San Francisco
  • Substance Abuse, Intravenous*
  • Tuberculin Test
  • Tuberculosis, Pulmonary / drug therapy
  • Tuberculosis, Pulmonary / prevention & control*
  • Urban Health

Substances

  • Antitubercular Agents
  • Isoniazid